Dolby’s yearly low brings attention to earnings strength, dividend support, licensing demand, and its role in entertainment ...
Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease -- Company Developing NPI as a Measure ...
Asianet Newsable on MSN
Cognition Therapeutics gets positive FDA feedback over phase 3 study of DLB psychosis – but CGTX stock just crashed 33%
The company reported that the U.S. Food and Drug Administration aligned with the company on several key aspects of the Phase 3 study, which is expected to begin in mid-2027.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Accenture acquires DLB. Consultancy giant Accenture this week signed an agreement to acquire a majority stake (65 percent) in ...
Credit: Getty Images Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a first-degree relative who has DLB, including a 2-fold ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results